image
ImmunityBio, Inc. IBRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.49
-7.8 %
$ 3.13 B
Market Cap
-5.41
P/E
INCOME STATEMENT
622 K REVENUE
159.17%
Growth Rates
1Year 159.17%
3Years 0.93%
5Years 67.62%
7Years 45.99%
10Years 0.36%
-362 M OPERATING INCOME
-3.12%
Growth Rates
1Year -3.12%
3Years -17.93%
5Years -29.78%
7Years -16.48%
10Years -66.08%
-583 M NET INCOME
-39.75%
Growth Rates
1Year -39.75%
3Years -37.53%
5Years -43.39%
7Years -25.22%
10Years -75.98%
EFFICIENCY
Earnings Waterfall ImmunityBio, Inc.
image
Revenue 622 K
Cost Of Revenue 18.5 M
Gross Profit -17.9 M
Operating Expenses 363 M
Operating Income -362 M
Other Expenses 221 M
Net Income -583 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 0.6 0.2 0.9 0.6 2.2 47 K 45 K 44 K 0.2 0.6 0.6
GROSS PROFIT
Cost Of Revenue 18.5 24.2 0 9.1 9.0 (3.1) 0 0 0 0 0.3
Gross Profit (17.9) (24.0) 0.9 (8.5) (6.8) 3.2 45 K 44 K 0.2 0.6 0.3
OPERATING INCOME
Operating Expenses 362.9 350.9 331.2 210.8 158.5 88.9 93.6 120.9 237.6 5.9 2.9
Selling, General and Administrative Expenses 129.6 102.7 135.3 71.3 46.5 35.5 53.8 94.4 226.2 4.3 2.4
Research and Development Expenses 232.4 248.1 196.0 139.5 112.0 53.4 39.8 26.5 11.4 1.6 0.4
Operating Income (362.2) (351.3) (330.3) (220.9) (156.3) (98.4) (99.1) (124.5) (238.9) (6.2) (2.3)
PRE-TAX INCOME
Interest Income Expense 129.2 63.5 14.8 9.1 5.9 0.4 0.6 66 K 0 0 0.5
Total Other Income (221.6) (66.0) (19.6) (25.4) (3.9) 1.7 2.2 3.1 1.7 (0.6) 0.2
Pre-Tax Income (583.9) (417.3) (349.8) (226.0) (160.3) (96.7) (96.9) (121.4) (237.2) (6.2) (2.0)
NET INCOME
Tax Provision 40 K 34 K 9 K (1.8) (0.1) (0.5) (0.5) (0.6) (0.3) 1 K 1 K
Net Income (583.2) (417.3) (349.8) (224.2) (160.2) (96.2) (96.4) (120.8) (236.9) (6.2) (2.0)
EPS 1.15 1.04 0.9 0.59 0.42 1.22 1.2 1.47 3.31 0.0197 2.57